American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 801–900 of 1,001
Hyperglycemia in Orthopaedic Trauma Patients: Implications, Management, and Future Directions
Belmonte, A. D., Roebke, L. J., & Shaikh, H. S. (2024) · Operative Techniques in Orthopaedics · doi:10.1016/j.oto.2024.101132 · Cited by 6
Luo, T., Zhou, R., & Sun, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319655 · Cited by 6
“The postoperative complications collected included glycemic control (random blood glucose values ≥ 180 mg/dl) [18]; the Clavien-Dindo classification of surgical complications (S1 Table) [19]; respiratory system complications, including pneumonia, atelectasis, pulmonary embolism, and respiratory…”
Olsen, M. T., Hansen, K. B., Pedersen‐Bjergaard, U., & Kristensen, P. L. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251331600 · Cited by 6
“1,21,22 This increases the external validity of the findings on the associations between THRH, TBR, and hypoglycemic events.”
Corticosteroid Use in Musculoskeletal and Neuraxial Interventions: Effects on Glycemic Control
Singer, B., Chaimovitz, D., Bucek, T., Dayon, E., Abbott-Korumi, A., Spatz, M., Makkapati, T., Petrosyan, H. A., & Delavaux, L. (2025) · Medicina · doi:10.3390/medicina61050936 · Cited by 6
“Any persistent hyperglycemia (blood glucose above 180 mg/dL) should prompt medical evaluation [65].”
Fayfman, M., Hochberg, I., Magee, M. F., RASHIED, A. A., Chaudhry, N. A., Jagannathan, R., Pasquel, F. J., & Umpierrez, G. E. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.014 · Cited by 6
Self-citationAssociation between glycemic variability and mortality in critically ill patients with heart failure
Liu, P., Li, Z., Tang, S., Dou, W., & Liu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-16212-0 · Cited by 6
Faulds, E. R., Rayan, M. N., Mlachak, M. K., Dungan, K. M., Allen, T., & Patterson, E. S. (2026) · Diabetology · doi:10.3390/diabetology7010019 · Cited by 6
Mohajir, W. A., O’Keefe, S. J., & Seres, D. S. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.07.002 · Cited by 6
Reagan, L., Laguerre, R. A., Todd, S., & Gallagher, C. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01581-x · Cited by 6
“The DSS intervention was informed by the National Standards of Diabetes Education [7] and DSS research [8, 10, 11] and the PI’s prior studies with incarcerated persons with diabetes [32–34] and is grounded in the IMB model [24, 25].”
Zhang, R., Wu, Y., Xv, R., Wang, W., Zhang, L., Wang, A., Li, M., Jiang, W., Jin, G., & Hu, X. (2024) · Nutrition in Clinical Practice · doi:10.1002/ncp.11143 · Cited by 6
“45 The aim of this trial was to observe the status of postoperative BG levels in patients without diabetes mellitus, defining hyperglycemia as BG exceeding 7.8 mmol/L (140 mg/dl) at any level in the hospital (that is, TIR 3.9 – 7.8 mmol/L, TAR >7.8 mmol/L, and TBR 3.9 mmol/L).”
InfluentialIn-Silico Validation of Insulin Sensitivity Prediction by Neural Network-based Quantile Regression
Alkhafaf, O. S., Alsultani, A. B., Roel, A. N., Szabó, B., Pintár, P., Szlávecz, Á., Paláncz, B., Kovács, K. J., Chase, J. G., & Benyó, B. I. (2024) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2024.11.065 · Cited by 6
Managing diabetes mellitus in the surgical patient
Coan, K. E., Apsey, H. A., Schlinkert, R. T., Stearns, J. D., & Cook, C. B. (2014) · Diabetes Management · doi:10.2217/dmt.14.42 · Cited by 6
Insulin therapy for hyperglycemia in neonatal sepsis using a preterm mouse model
Miyauchi, H., Fujioka, K., Okubo, S., Nishida, K., Ashina, M., Ikuta, T., Okata, Y., Maeda, K., Iijima, K., & Bitoh, Y. (2019) · Pediatrics International · doi:10.1111/ped.14126 · Cited by 6
Things we do for no reason™: Routinely holding metformin in the hospital
Cohen, D. A., Ricotta, D. N., & Parikh, P. D. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3644 · Cited by 6
Tight glycaemic control and surgical site infections post cardiac surgery: a systematic review
Hweidi, I. M., Zytoo, A. M., & Hayajneh, A. A. (2021) · Journal of Wound Care · doi:10.12968/jowc.2021.30.sup12.s22 · Cited by 6
Sulfikar, A., Irwan, A. M., & Restika, I. (2023) · International Journal of Nursing and Health Services (IJNHS) · doi:10.35654/ijnhs.v6i2.695 · Cited by 6
“Chronic hyperglycemia in DM will be accompanied by damage and impaired function of several organs, especially the eyes, kidneys, nerves, heart, and blood vessels (1).”
BackgroundEllahham (2010) · Clinical Epidemiology · doi:10.2147/clep.s15162 · Cited by 6
“1 mmol/L (,110 mg/dL) not recommended.(18) It should be noted that insulin therapy is not without potential harm.”
NADAL, M. D., Prat, I. C. D., Cervantes, A. C., Pérez, P. T., Graupera, C. B., & Idáñez, Á. M. (2013) · Revista Española de Anestesiología y Reanimación · doi:10.1016/s0034-9356(13)70014-8 · Cited by 6
Control of serum glucose concentration in critical illness
Kandil, S. B., Miksa, M., & Faustino, E. V. S. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328360c6a0 · Cited by 6
The future of inpatient diabetes management: glucose as the sixth vital sign
Rendell, M., Saiprasad, S., Trepp-Carrasco, A. G., & Drincic, A. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.1 · Cited by 6
Cultivating Quality: An Evidence-Based Protocol for Managing Hypoglycemia
McEuen, J. A., Gardner, K. P., Barnachea, D. F., Locke, C., Backhaus, B. R., & Hughes, S. K. (2010) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000383933.45591.1c · Cited by 6
Hellman, R. (2014) · Endocrine Practice · doi:10.4158/ep14283.co · Cited by 6
Self-citationTang, C., & Kouides, R. W. (2014) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v4.25755 · Cited by 6
“According to American Association of Clinical Endocrinologist and American Diabetes Association consensus, inpatient pre-meal BG target for non-critically ill patients is 70 140 mg/dl and BG target for critically ill patients is 140 180 mg/dl (6).”
BackgroundRousing, M. L., Pielmeier, U., & Andreassen, S. (2014) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2013.12.008 · Cited by 6
Jacobson, L. A., Jerguson, K., Spiva, L., & Fraser, D. D. (2012) · Pharmacy Practice · doi:10.4321/s1886-36552012000100008 · Cited by 6
In‐hospital metabolic regulation in patients with a diabetic foot ulcer: is it worthwhile?
Egan, A. M., & Dinneen, S. F. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2741 · Cited by 6
“Patients with diabetes are more likely to be hospitalized and experience a longer duration of hospital stay than those without [14].”
BackgroundMasse, J., Giuliano, C. A., Brown, S. A., & Paxton, R. A. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616677030 · Cited by 6
“Current guidelines recommend initiating insulin therapy when BG values are greater than 180 mg/dL in critically ill patients.(10) A BG target of less than 180 mg/dL has shown to decrease mortality when compared to more strict glucose control (BG <110 mg/dL) in medical intensive care unit (ICU) and”
Sudlow, A. C., O'Connor, H. M., Narwani, V., Swafe, L., & Dhatariya, K. (2017) · Practical Diabetes · doi:10.1002/pdi.2098 · Cited by 7
Transitioning from intravenous to subcutaneous insulin in the medical intensive care unit
Zhou, K., Williams, M. F., Esquivel, M. A., Song, A., Rahman, F., Bena, J., Lam, S. W., Rathz, D. A., & Lansang, M. C. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.016 · Cited by 6
Woo, S., Nah, S., Kim, M., Moon, J. E., & Han, S. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.08.031 · Cited by 6
Insulin Therapy for Hyperglycemia Management in Critically Ill Patients
Eastman, D. K., Butler, J., Dicken, S., & Bottenberg, M. M. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115025 · Cited by 6
Drews, H., Castiglione, A. L., Brentin, S. N., Ersig, C., Dukatz, T., Harrison, B. E., Omran, F. M., & Rosenblatt, S. (2012) · PubMed · Cited by 6
Preprocedure and Preoperative Management of Diabetes Mellitus
Bodnar, T. W., & Gianchandani, R. Y. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.10.2822 · Cited by 6
Medicación crónica durante el preoperatorio: ¿suspender o no suspender?
López-Álvarez, A., Román-Fernández, A., Fernández-Vieitez, M. B., & Puertas, S. F. (2013) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2013.06.005 · Cited by 6
“suspensión temporal solo condiciona la recurrencia de síntomas menopáusicos, se recomienda hacerlo de 4 a 6 semanas antes de la cirugía, además de hacer profilaxis tromboembólica .”
Ena, J., Casañ, R., Carratalá, M. J., & Leutscher, E. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.22038 · Cited by 6
“The recently published standards for diabetes care in hospitalized patients admitted to general medicine or surgical wards recommended maintaining blood glucose values below 180 mg/dL if they can be achieved safely [8].”
BackgroundManagement of the Hospitalized Diabetes Patient with an Insulin Pump
McCrea, D. L. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.010 · Cited by 6
Inzucchi, S. E., & Sherwin, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00562-5 · Cited by 6
Self-citationLi, H., Lu, C., Wang, J., Yin, G. P., Sun, R., Xu, X. H., Liu, B. L., Li, F., Jing, T., Lee, K., et al. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0712-0 · Cited by 6
Rao, R. H., Perreiah, P. L., & Cunningham, C. A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821995568 · Cited by 6
Copeptin and stress-induced hyperglycemia in critically ill patients: A prospective study
Henrique, L. R., Crispim, D., Vieceli, T., Schaeffer, A. F., Bellaver, P., Leitão, C. B., & Rech, T. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250035 · Cited by 6
“Hyperglycemia was defined based on the threshold proposed by the American Diabetes Association [22] for in-hospital hyperglycemia as any blood glucose measurement > 140 mg/dL at ICU admission [23].”
MethodTilinca, M. C., Gliga, M. C., & Varga, A. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2021-0024 · Cited by 6
“Therefore, a rapid adjustment method of insulin delivery to address fluctuations in glucose levels is vital for critically ill COVID-19 patients with DKA [50,51].”
MethodManagement of Hyperglycemia in Hospitalized, Non–Critically Ill Adults
Chang, L. L., Umpierrez, G. E., & Inzucchi, S. E. (2022) · New England Journal of Medicine · doi:10.1056/nejmclde2204691 · Cited by 6
Self-citationThe Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
Ma, J., Zhou, H., Xu, H., Xie, C., Teng, X., Liu, Q., & Liu, W. (2015) · Journal of Diabetes Research · doi:10.1155/2016/7245947 · Cited by 6
“Intravenous infusion of insulin was previously used to achieve glycaemic target for patients in the Intensive Care Unit [12] and those with diabetic ketoacidosis due to the rapid action and shorter half-life [13].”
MethodA Retrospective Review of Sliding Scale vs. Basal/Bolus Insulin Protocols
Rymaszewski, H., & Breakwell, S. (2013) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2013.03.001 · Cited by 6
O Pensamento Histórico de Francisco Manuel de Melo.
Amado, M. T. (1993) · Penélope (Lisboa · Cited by 6
Braithwaite, S. S., Godara, H., Song, J., Cairns, B. A., Jones, S., & Umpierrez, G. E. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300432 · Cited by 6
Self-citationThe futile cycle of hospital readmission in patients with diabetes
Swami, J., & Korytkowski, M. T. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.06.006 · Cited by 6
Self-citationKoracevic, G. P. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.10.038 · Cited by 6
Amir, M., Sinha, V., Kistangari, G., & Lansang, M. C. (2020) · Endocrine Practice · doi:10.4158/ep-2018-0524 · Cited by 5
Zanjanchi, F., Zeidi, I. M., Morshedi, H., Zeidi, B. M., Maleki, M. R., & Hajia, A. P. (2023) · Clinical Diabetology · doi:10.5603/cd.96203 · Cited by 5
The Contributing Factors to the Risk of Diabetes Mellitus among Indonesian Urban Workers
Mahmudah, M., Izza, N., Indrawati, L., Paramita, A., & Indriani, D. A. A. (2025) · Nurse Media Journal of Nursing · doi:10.14710/nmjn.v15i1.56916 · Cited by 5
Neri, G., Bruni, A., Garofalo, E., Longhini, F., & Bosco, V. (2025) · Healthcare · doi:10.3390/healthcare13182313 · Cited by 5
“First, clinical governance must ensure that protocols are not only evidence-based but also dynamic, allowing for appropriate flexibility in high-acuity settings where rigid adherence may compromise patient care [44,45].”
Practical approach to clinical controversies in glycemic control for hospitalized surgical patients
Ware, L. R., Gilmore, J. F., & Szumita, P. M. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10858 · Cited by 5
Zhou, Y., Wang, Z., Ospel, J. M., Goyal, M., McDonough, R. V., Yang, P., Zhang, Y., Zhang, L., Ye, X., Wei, F., et al. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01281-0 · Cited by 5
Lee, D. H., Lee, B. K., Cho, Y. S., Jung, Y. H., Lee, H. Y., Jeung, K. W., Youn, C. S., Kim, S. H., & on behalf of Korean Hypothermia Network Investigators (2022) · PLoS ONE · doi:10.1371/journal.pone.0279776 · Cited by 5
Leal, J., Wellman, S. S., Jiranek, W. A., Seyler, T. M., Bolognesi, M. P., & Ryan, S. P. (2024) · The Journal of Arthroplasty · doi:10.1016/j.arth.2024.02.069 · Cited by 5
Tiwari, R. K., Ahmad, A., Chadha, M., Saha, K., Verma, H., Borgohain, K., & Shukla, R. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998294919240506044544 · Cited by 5
Antidiabetic Drugs Consumption in France Over a Decade: An Observational Study
Bandt, D. D., Mezence, J., Rives‐Lange, C., Menges, D., & Carette, C. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.02.005 · Cited by 5
Mokta, J. K., Kumar, S., Ganju, N., Mokta, K., Panda, P. K., & Gupta, S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.196019 · Cited by 5
Ketz, J. M., Yeh, E. J., & Suri, S. (2019) · Clinical Diabetes · doi:10.2337/cd19-0003 · Cited by 5
“The AACE/ADA consensus statement on inpatient diabetes control recommends basal-plus-correctional and BMC regimens and discourages prolonged use of SSI monotherapy for control of hyperglycemia in hospitalized patients (11).”
BackgroundTiming of Insulin with Meals in the Hospital: a Systems Improvement Approach
Dungan, K. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1232-4 · Cited by 5
Intravenous insulin for the management of non-emergent hyperglycemia in the emergency department
Koscal, L. J., Weeda, E. R., Matuskowitz, A. J., & Weant, K. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.08.078 · Cited by 5
Hochfellner, D. A., Rainer, R., Ziko, H., Aberer, F., Simic, A., Lichtenegger, K. M., Beck, P., Donsa, K., Pieber, T. R., Fruhwald, F. M., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14458 · Cited by 5
“The occurrence of both hyperglycaemic and hypoglycaemic events in hospitalized patients with diabetes is associated with adverse outcomes.(1) Hospitals should therefore promote safe inpatient stay with an efficient transition to the outpatient setting.”
BackgroundBrož, J., Žďarská, D. J., Urbanová, J., Piťhová, P., Doničová, V., Pálová, S., Pelechová, B., Smržová, A., & Kvapil, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01080-4 · Cited by 5
Urai, S., Hashimoto, N., Takabe, M., Kawashima, M., Satake, Y., Nishimoto, Y., Kuroda, M., Yamane, Y., Doi, K., Oue, T., et al. (2021) · Journal of Artificial Organs · doi:10.1007/s10047-021-01286-0 · Cited by 5
In-Hospital Mortality and Glycemic Control in Patients with Hospital Hyperglycemia
Russo, M. P., Fosser, S. M., Elizondo, C. M., Giunta, D. H., Fuentes, N. A., & Ratti, M. F. G. (2021) · The Review of Diabetic Studies · doi:10.1900/rds.2021.17.50 · Cited by 5
“mong hospitalized patients, both hyperglycemia and hypoglycemia are associated with adverse outcomes, including death [1, 2].”
BackgroundAhmed, S., & Styers, J. P. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.006 · Cited by 5
Role of the Diabetes Educator in Inpatient Diabetes Management
American Association of Diabetes Educators (2018) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721718820944 · Cited by 5
Case 58: Extreme Insulin Resistance Following Heart Transplant
Gupta, S., Oakes, D. J., Therasse, A., Wallia, A., & Molitch, M. E. (2015) · American Diabetes Association eBooks · doi:10.2337/9781580405713.58 · Cited by 5
Schwartz, X., Porter, B. A., Gilbert, M. P., Sullivan, A., Long, B., & Lentz, S. A. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2023.04.018 · Cited by 5
Dey, A. K., Gokalani, R. A., Kale, M. C., Sankar, P., Saboo, B., Maheshwari, A., Jaggi, S., Jagadeesha, A., Panchal, D., Chawla, M. S., et al. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_121_23 · Cited by 5
Pharmacotherapy of hyperglycemia in type 2 diabetes mellitus
Weinert, L. S., Camargo, E. G., & Silveiro, S. P. (2010) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 5
Gauthier, L., Ferguson, J., Dubé, A.-I., Nguyen, P. V.-Q., Beauchesne, M.-F., & Boutin, J. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.012 · Cited by 5
Effects of Glycemia on Immediate Complications Followings Cabg
Cunningham, G. R., Daoud, D., Baimbridge, S., Baimbridge, C., & Abdelnour, S. (2013) · Endocrine Practice · doi:10.4158/ep12378.or · Cited by 5
Nseir, W., Haj, S., Beshara, B., Mograbi, J., & Cohen, O. (2013) · International Journal of Endocrinology · doi:10.1155/2013/371608 · Cited by 5
“The glycemic control goals in nonsurgical hospitalized patients continue to be debated, but a consensus defining upper limits below 180m/dL in noncritical patients is well based on outcomes studies and is therefore recommended by recent position papers [14].”
BackgroundVariability of insulin sensitivity during the first 4 days of critical illness
Pretty, C. G., Compte, A. L., Chase, J. G., Shaw, G. M., Preiser, J.-C., Penning, S., & Desaive, T. (2012) · Critical Care · doi:10.1186/cc10774 · Cited by 5
Transitioning From Inpatient to Outpatient Therapy in Patients with In-Hospital Hyperglycemia
Peterson, G. M. (2011) · Hospital Practice · doi:10.3810/hp.2011.10.927 · Cited by 5
“Successful coordination of this transition requires a team approach, which may involve physicians, nurses, pharmacists, medical assistants, dietitians, case managers, and social workers.(10) Specifi cally, AACE guidelines suggest that for patients without previous diagnosis of diabetes and an HbA 1c level 6.”
BackgroundEmerging New Trends in Neurosurgical Technologies
Zhang, Y., Zhao, D., Li, H., Li, Y., Zhu, X., & Zhang, X. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9891-x · Cited by 5
“The subjects with pre-existing diabetes mellitus are at lesser risk than those unknown cases of hyperG [57].”
BackgroundVenkitachalam, L., McGuire, D. K., GOSCH, K. L., Lipska, K. J., Inzucchi, S. E., Lind, M., Goyal, A., Spertus, J. A., Masoudi, F. A., Jones, P. G., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.012 · Cited by 5
Self-citationManagement of Hyperglycemia in the Intensive Care Unit
Brady, V. (2012) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2012.11.003 · Cited by 5
Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy
Pollom, R. D. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.346 · Cited by 5
“Although no prospective studies have been conducted in noncritically ill patients, the ADA/AACE statement recommends premeal glucose targets 140 mg/dL in conjunction with random blood glucose targets 180 mg/dL in this population.(12) Although there are no large prospective clinical trials suffi ciently powered to dete…”
BackgroundMethodResultInfluentialAnalytical performance of glucometers in a tertiary care hospital
Higioka, A. S., Rudolf‐Oliveira, R. C. M., Martinello, F., & Bazzo, M. L. (2016) · Accreditation and Quality Assurance · doi:10.1007/s00769-015-1188-2 · Cited by 5
Zein, A. F. M. Z., Nasution, S. A., Purnamasari, D., & Mansjoer, A. (2015) · Acta medica Indonesiana · Cited by 5
Long-Acting Insulin on the Road to Recovery With Diabetic Ketoacidosis
Bunn, S., & Halm, M. A. (2016) · American Journal of Critical Care · doi:10.4037/ajcc2016681 · Cited by 5
Reducing Mortality in the Perioperative Period
Landoni, G., Zangrillo, A., & Ruggeri, L. (2013) · Springer eBooks · doi:10.1007/978-3-319-02186-7 · Cited by 5
Physiology and Pharmacology of Obesity, Pediatrics, and the Elderly
Johnson, K. B., Bailey, T. L., & Thackeray, E. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00005-3 · Cited by 5
Zhang, X., Zhang, T., Xiang, G., Wang, W., Li, Y., Du, T., Zhao, Y., Mosha, S. S., & Li, W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001261 · Cited by 5
Principles of Geriatric Pharmacotherapy
Devlin, J. W., & Barletta, J. F. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316676325.004 · Cited by 5
In-Silico Trials for Glucose Control in Hospitalized Patients with Type 2 Diabetes
Choi, K., Oh, T. J., Lee, J. C., Kim, M.-J., Kim, H. C., Cho, Y. M., & Kim, S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.2.231 · Cited by 5
“������ �� � ����� ��������� � ����� ��������� (2)”
BackgroundInfluentialInsulin IP Calc: A smartphone application for insulin infusion protocol in Intensive Care Units
Karippacheril, J. G., Mathai, R. T., & Abraham, S. (2015) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.171607 · Cited by 5
“[4] In view of this, the revised consensus guidelines of the American Association of Clinical Endocrinology and American Diabetes Association recommended a blood glucose target of 140–180 mg/dL.[4] Accordingly, the Yale insulin infusion protocol was modified and updated to a blood glucose target of 120–160 mg/dL by Sh…”
BackgroundPhytochemical Screening and Anti-diabetic Evaluation of Citrus sinensis Stem Bark Extracts
Boris, A. K., Djuikoo, I. L. N., Wilfried, K., Takuissu, G. R., Ngondi, J. L., & Oben, J. E. (2017) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2017/34051 · Cited by 5
“Metabolic syndrome including obesity and diabetes as individual components is the most prevailing health concern worldwide and its incidence is increasing at a high rate, resulting in enormous social costs [2-37].”
BackgroundShogbon-Nwaesei, A. O., Jacob, B. C., Kimble, L. P., Peasah, S. K., Burtner, J. A., Moody, L., Ngo, D., & Ryan, G. J. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017743132 · Cited by 5
“Achieving glycemic control is vitally important when managing patients in the inpatient setting given the association between hyperglycemia and adverse patient outcomes, including increased hospital length of stay and death.(1,2) Subcutaneously administered insulin incorporating basal, nutritional, and correctional co…”
BackgroundInpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD
Everett, E. M., & Mathioudakis, N. N. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1026-0 · Cited by 5
Chen, Y., Kao, S. L., Tan, M. L. S., Ning, Y., Salloway, M. K., Wee, H. L., Venkataraman, K., Khoo, E. Y. H., Chow, Y. L., Tai, E. S., et al. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.09.006 · Cited by 5
Gregory, A. J., Engelman, D. T., Williams, J. B., Arora, R. C., & Boyle, E. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-33443-7_51 · Cited by 5
Glycemic Control for Critically Ill Patients Using Zone Model Predictive Control
Wu, S., Furutani, E., Sugawara, T., Asaga, T., & Shirakami, G. (2020) · IEEJ Transactions on Electrical and Electronic Engineering · doi:10.1002/tee.23294 · Cited by 5
Satomura, A., Oikawa, Y., Nakanishi, S., Takagi, S., Mizutani, G., Iida, S., Nakayama, H., Haga, Y., Nagata, M., Maesaki, S., et al. (2021) · Diabetology International · doi:10.1007/s13340-021-00500-x · Cited by 5
Kyazze, A. P., Bongomin, F., Ninsiima, S., Nattabi, G., Nabakka, W., Kukunda, R., Odanga, H., Ssekamatte, P., Baluku, J. B., Kibirige, D., et al. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211009380 · Cited by 5
Korakas, E., Argyropoulos, T., Koliou, G.-A., Gikas, A., Kountouri, A., Kostaridou, S., Plotas, P., Kontoangelos, K. A., Ikonomidis, I., Kadoglou, N. P. E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051301 · Cited by 5
“Introduction According to the latest American Diabetes Association and American Association of Clinical Endocrinologists consensus, stress hyperglycemia (SH) is defined as any transient inpatient plasma glucose levels >140 mg/dL under conditions of acute physical or psychological stress, without evidence of previous d…”
BackgroundSon, K. H., Kim, W., Kwak, J. G., Choi, C. H., Lee, S. I., Ko, U. W., Kim, H. S., Lee, H., Chung, E.-S., Kim, J.-B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175106 · Cited by 5
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.